| Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma–COPD overlap: a systematic review and meta-analysis JE Amegadzie, J Gorgui, L Acheampong, JM Gamble, J Farrell, Z Gao Journal of Asthma 58 (3), 344-359, 2021 | 15 | 2021 |
| Gender differences in inhaled pharmacotherapy utilization in patients with obstructive airway diseases (OADs): a population-based study JE Amegadzie, JM Gamble, J Farrell, Z Gao International journal of chronic obstructive pulmonary disease, 2355-2366, 2020 | 14 | 2020 |
| Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study JE Amegadzie, JM Gamble, J Farrell, Z Gao International Journal of Chronic Obstructive Pulmonary Disease, 1205-1217, 2022 | 10 | 2022 |
| Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada JE Amegadzie, TY Lee, M Sadatsafavi, LD Lynd, DD Sin, KM Johnson CMAJ 195 (35), E1172-E1179, 2023 | 9 | 2023 |
| QRISK3 underestimates the risk of cardiovascular events in patients with COPD JE Amegadzie, Z Gao, JK Quint, R Russell, JR Hurst, TY Lee, DD Sin, ... thorax 79 (8), 718-724, 2024 | 5 | 2024 |
| Validated methods to identify patients with asthma–COPD overlap in healthcare databases: a systematic review protocol JE Amegadzie, O Badejo, JM Gamble, M Wright, J Farrell, B Jackson, ... BMJ open 9 (3), e024306, 2019 | 3 | 2019 |
| The increasing burden of asthma acute care in Singapore: an update on 15-year population-level evidence LHM Lim, W Chen, JE Amegadzie, HF Lim BMC Pulmonary Medicine 23 (1), 502, 2023 | 1 | 2023 |
| A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk JE Amegadzie, M Sadatsafavi European Respiratory Journal 62 (2), 2023 | 1 | 2023 |
| Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap JE Amegadzie, JM Gamble, J Farrell, Z Gao Respiratory Research 23 (1), 364, 2022 | 1 | 2022 |
| The high burden of asthma acute care in Singapore and the impact of guideline-based asthma treatment and COVID-19 L Lim, HF Lim, MF Liew, J Amegadzie, W Chen RESPIROLOGY 28, 336-337, 2023 | | 2023 |
| THE HIGH BURDEN OF ASTHMA ACUTE CARE IN SINGAPORE IN THE NEXT 20 YEARS LHM Lim, W Chen, M Sadatsafavi, J Amegadzie, HF Lim CHEST 164 (4), A28, 2023 | | 2023 |
| ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)? J Amegadzie, Z Gao, JK Quint, R Russell, J Hurst, TY Lee, W Chen, ... CHEST 164 (4), A4988-A4989, 2023 | | 2023 |
| Pharmaco-epidemiological study of cardiorespiratory safety of β2-agonists for the treatment and management of asthma, chronic obstructive pulmonary disease (DOPD) and asthma … JE Amegadzie Memorial University of Newfoundland, 2021 | | 2021 |
